Huangshi Shixing Pharmaceutical Co., Ltd., formerly known as Huangshi City, the fourth pharmaceutical factory.Corporate restructuring, the business of Huangshi Institute of Leadership and re-established a joint venture to form a management holding shares of the new technology enterprises universities. The company is located in Big Spring Road Yellowstone Economic and Technological Development Zone biomedical industrial park, east of Yangtze River, north of Shanghai-Chengdu Expressway, the factory area of 20,000 square meters, two mountains, beautiful scenery and convenient transportation. In 2012 the company has equity transformation by Jin card company, Guangdong Kubo and management of the company to form a new joint stock company, and in 2013 in Jinshan Avenue Yellowstone high-tech development zones, covering 200 acres of new countries, a new pharmaceutical raw materials production base, officially put into operation early in 2015. As an enterprise mainly producing bulk pharmaceutical chemicals, our company passed GMP certification at the end of January 2005, with the main production varieties of erythromycin ethylsuccinate, erythromycin estolate, hydruobenzole hydrochloride, dexketoprofen, dexketoprofen tromethamine, diphenhydramine citrate, cinepazide maleate and erythrocin, mature technology, rich experience, excellent quality, as well as the varieties of lansoprazole, menadiol sodium diphosphate, roxithromycin, azithromycin, clarithromycin and so on which will be successively put on the market. With the technology relying on Department of Pharmacy in Huangshi Institute of Technology, our new company has strong development and transformation capacities. Laying emphasis on talent cultivation, our company now has 10 employees with middle and high-level technical title, 22 employees with intermediate title and 6 licensed pharmacists, with 80% production workers possessing technical secondary school and above, thus meeting the production requirements. Over the past more than ten years, our company has won the praises of customers by virtue of advanced technology, high quality and cordial service in the business policy of “Survive on Quality, Develop by Credit”, successively established a business contract relationship with many enterprises of China, and formed a strategic partnership with a group of associate organizations in long-term operation. Looking into the future, our company sincerely hopes to cooperate with more manufacturers and operating units of domestic and foreign research institutes, and establish a friendly relationship, to create a better future of Shixing Pharmaceutical together with further support and help of medical insiders.